Jean-Loup Romet-Lemonne, MD

Dr. Romet-Lemonne is the President and Co-founder of Traverse Biotech. His extensive experience and expertise in the field of immunology and cancer research have positioned him as a key leader in the development of innovative cancer therapies.

Prior to his role at Traverse Biotech, he was the founder and CEO of IDM Pharma, Inc., which was later acquired by Takeda Oncology. During his academic and scientific training, Dr. Romet-Lemonne served as a Senior Scientist in the Cancer Biology Department at the Harvard School of Public Health and as an Associate Professor at the University of Tours School of Medicine in France.

Dr. Romet-Lemonne received his MD from Tours University, completed business training at HEC in France, and executive training at Stanford University’s Graduate School of Business.